These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 895327)

  • 21. Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy.
    Artz SA; Paes IC; Faloon WW
    Gastroenterology; 1966 Dec; 51(6):1046-53. PubMed ID: 5958605
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of antibiotics on arterial hyperammonemia induced in liver cirrhosis patients by diuretics causing hypokalemia].
    Imler M; Bockel R; Peter B; Stahl J
    Pathol Biol (Paris); 1971; 19(11):567-73. PubMed ID: 4933620
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial].
    Blanc P; Daurès JP; Liautard J; Buttigieg R; Desprez D; Pageaux G; Allaz JL; Parelon G; Larrey D; Michel H
    Gastroenterol Clin Biol; 1994; 18(12):1063-8. PubMed ID: 7750678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of hepatic encephalopathy. Personal experience and a review of the literature].
    Cipollini F; Amadio R; Altilia F
    G Clin Med; 1982 Oct; 63(10):753-67. PubMed ID: 6133806
    [No Abstract]   [Full Text] [Related]  

  • 25. [Eliciting factors and clinical picture of hepatic coma in 152 patients with cirrhosis of the liver (author's transl)].
    Müting D; Sommer A
    MMW Munch Med Wochenschr; 1979 Mar; 121(13):453-6. PubMed ID: 107423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ambulatory diagnosis and therapy control of portasystemic encephalopathy in patients with liver cirrhosis].
    Rink C; Mantel E; Haerting J; Nilius R
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):295-301. PubMed ID: 4092654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatic encephalopathy. Physiopathology and treatment].
    Perney P; Pomier-Layrargues G
    Gastroenterol Clin Biol; 1994; 18(12):1069-76. PubMed ID: 7750679
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term treatment of portal-systemic encephalopathy with lactulose.
    Ma MH; McLeod JG; Blackburn CR
    Australas Ann Med; 1969 May; 18(2):117-23. PubMed ID: 5793699
    [No Abstract]   [Full Text] [Related]  

  • 30. Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.
    Pedretti G; Calzetti C; Missale G; Fiaccadori F
    Ital J Gastroenterol; 1991 May; 23(4):175-8. PubMed ID: 1751811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Countermeasures for hepatic encephalopathy complicated with liver cirrhosis].
    Watanabe A
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1625-30. PubMed ID: 1774529
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of portosystemic encephalopathy].
    Ventrella F; Tardi S; Palmieri V
    Clin Ter; 1986 May; 117(4):317-28. PubMed ID: 3731738
    [No Abstract]   [Full Text] [Related]  

  • 34. [Early diagnosis and therapy of hepatic coma in viral hepatitis--theoretical concepts and practical possibilities].
    Baumgarten R; Fengler JD; Markus R
    Z Arztl Fortbild (Jena); 1982 Apr; 76(7):286-8. PubMed ID: 7101985
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of portal-systemic encephalopathy: the practical and the promising.
    Weber FL
    Gastroenterology; 1981 Jul; 81(1):174-7. PubMed ID: 7239116
    [No Abstract]   [Full Text] [Related]  

  • 39. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
    Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS
    Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.